NovaDel Pharma (NVD) Names Zodda as Interim CFO
More News related to NVD
- NovaDel (NVD) Enters Possible $2M Agreement with Mist Acquisition to Manufacture and Commercialize NitroMist
- NovaDel Licenses its NitroMist(R) Lingual Spray to Mist
- NovaDel Holds Annual Meeting
- StockPreacher.com Issues Trading Outlook for Novadel Pharma Inc.
- NovaDel Pharma (NVD) Receives Commitment From Seaside 88 to Purchase Up To 13 Million Shares
NovaDel Pharma Inc. (NYSE: NVD) today announced Michael Spicer’s resignation, effective April 1, 2009, as CFO and Corporate Secretary of the Company, in order to accept a position at another company.
Deni Zodda, Ph.D., the Company’s Chief Business Officer, has been appointed Interim CFO and Corporate Secretary.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
